Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and ...

UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, ...

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment of the first patient in the ARTIZEN pivotal trial, evaluating the ...

The global hearing aids market is projected to grow at a rate of 6–7% over the next five years. This growth is driven by several key factors, including an expanding geriatric population, ongoing ...

FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, while safe, ...

Sara Mearns, the first principal dancer with hearing loss at the renowned New York City Ballet, joins Phonak, a global leader in hearing care solutions, as Brand Ambassador and Hearing Health Champion ...

A newly discovered CPD gene mutation causes hearing loss, and scientists found that Viagra and arginine may help reverse it.

At $131, you’re getting premium wireless earbuds for less than many mid-tier competitors charge. The AirPods Pro 3 bring ...

The Acclaim cochlear implant received Breakthrough Device Designation from the FDA in 2019 and is currently under investigation as part of a U.S.-based pivotal clinical trial. For more information on ...

The good news is that treating hearing problems could reduce cognitive decline by up to 48% and recent FDA changes now make ...

Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions ...